MedEquities Realty Trust Inc (NYSE:MRT) announced a quarterly dividend on Thursday, February 8th, Wall Street Journal reports. Shareholders of record on Monday, February 19th will be given a dividend of 0.21 per share by the financial services provider on Monday, March 5th. This represents a $0.84 annualized dividend and a yield of 7.93%. The ex-dividend date is Thursday, February 15th.
MedEquities Realty Trust (MRT) traded up $0.17 during trading on Thursday, reaching $10.59. The company’s stock had a trading volume of 175,034 shares, compared to its average volume of 155,854. MedEquities Realty Trust has a 1-year low of $10.06 and a 1-year high of $13.06. The stock has a market cap of $337.88, a price-to-earnings ratio of 26.40 and a beta of -0.73.
In other news, Director Randy L. Churchey acquired 5,300 shares of the firm’s stock in a transaction on Monday, November 20th. The shares were bought at an average price of $10.87 per share, for a total transaction of $57,611.00. Following the acquisition, the director now owns 46,776 shares of the company’s stock, valued at approximately $508,455.12. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO John W. Mcroberts acquired 18,000 shares of the firm’s stock in a transaction on Friday, November 17th. The stock was purchased at an average price of $10.74 per share, for a total transaction of $193,320.00. The disclosure for this purchase can be found here. Insiders have bought a total of 23,600 shares of company stock worth $254,129 in the last quarter. Insiders own 2.50% of the company’s stock.
A number of brokerages have recently issued reports on MRT. KeyCorp set a $13.00 target price on MedEquities Realty Trust and gave the company a “buy” rating in a research report on Sunday, October 29th. B. Riley reiterated a “buy” rating on shares of MedEquities Realty Trust in a research report on Wednesday, November 1st. Capital One Financial began coverage on MedEquities Realty Trust in a research report on Monday, October 23rd. They set an “equal weight” rating and a $13.00 target price on the stock. Zacks Investment Research upgraded MedEquities Realty Trust from a “sell” rating to a “hold” rating and set a $12.00 target price on the stock in a research report on Wednesday, November 15th. Finally, ValuEngine upgraded MedEquities Realty Trust from a “hold” rating to a “buy” rating in a research report on Friday, December 1st. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $13.00.
COPYRIGHT VIOLATION NOTICE: This piece was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was stolen and reposted in violation of international trademark & copyright laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/15/medequities-realty-trust-inc-mrt-declares-0-21-quarterly-dividend.html.
MedEquities Realty Trust Company Profile
MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.
Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.